The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. ImageneBio Inc shares valued at $2,499,969 were purchased by Bonita David P on Jul 25 ’25. At $29.90 per share, Bonita David P acquired 83,611 shares. The insider’s holdings grew to 287,885 shares worth approximately $1.68 million following the completion of this transaction.
Also, Stampacchia Otello purchased 267,556 shares, netting a total of over 7,999,924 in proceeds. Following the buying of shares at $29.90 each, the insider now holds 454,982 shares.
Analysts at Leerink Partners started covering the stock with ‘”an Outperform”‘ outlook in a report released in late October.
Analyzing IMA Stock Performance
On last trading session, ImageneBio Inc [NASDAQ: IMA] plunged -0.85% to $5.85. The stock’s lowest price that day was $5.7598, but it reached a high of $6.1603 in the same session. During the last five days, there has been a drop of approximately -6.25%. Over the course of the year, ImageneBio Inc shares have dropped approximately -68.55%. Shares of the company reached a 52-week high of $20.40 on 01/06/25 and a 52-week low of $5.76 on 12/24/25.
Support And Resistance Levels for ImageneBio Inc (IMA)
According to the 24-hour chart, there is a support level at 5.69, which, if violated, would cause prices to drop to 5.52. In the upper region, resistance lies at 6.09. The next price resistance is at 6.32. RSI (Relative Strength Index) is 28.86 on the 14-day chart, showing oversold technical sentiment.
Is ImageneBio Inc subject to short interest?
Stocks of ImageneBio Inc saw a sharp rise in short interest on 2025-11-28 jumping by 8543.0 shares to 0.38 million. Data from Yahoo Finance shows that the short interest on 2025-10-31 was 0.37 million shares. A jump of 2.28% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 9.63 of the overall float, the days-to-cover ratio (short ratio) jumped to 9.63.
Which companies own the most shares of ImageneBio Inc (IMA)?
In terms of ImageneBio Inc share price expectations, FactSet research, analysts set an average price target of 1.33 in the next 12 months, down nearly -77.46% from the previous closing price of $5.9. Analysts anticipate ImageneBio Inc stock to reach 1.33 by 2025, with the lowest price target being 1.33.
